Researchers have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.
from All Top News -- ScienceDaily https://ift.tt/TzsVRQ9
from All Top News -- ScienceDaily https://ift.tt/TzsVRQ9
Comments
Post a Comment